
1. General Information
Olmecip 40mg Tablet is an antihypertensive medicine containing Olmesartan Medoxomil 40mg. It is prescribed to lower and control elevated blood pressure. By controlling hypertension, it can help reduce the long-term risk of cardiovascular complications such as heart attack and stroke.
Brand: Olmecip 40mg Tablet
Active Ingredient: Olmesartan Medoxomil 40mg
Therapeutic Class: Antihypertensive
Drug Class: Angiotensin II Receptor Blocker (ARB)
Dosage Form: Tablet
Route: Oral
Manufacturer/Marketer: Cipla Ltd.
2. Product Information
Olmecip 40mg contains 40mg of Olmesartan Medoxomil. It is generally prescribed for the management of hypertension and may be used alone or together with other blood-pressure-lowering medicines depending on the patient's condition and doctor's assessment.
The medicine is supplied as oral tablets and should be stored according to the manufacturer's instructions. One current pharmacy listing specifies storage below 30°C.
3. Uses of Olmecip 40mg
Olmecip 40mg is primarily used for:
Treatment and management of high blood pressure (hypertension)
Helping maintain blood pressure within the target range
Reducing the long-term cardiovascular risks associated with uncontrolled hypertension
Supporting reduction of the risk of complications such as heart attack and stroke through effective blood-pressure control
4. Benefits of Olmecip 40mg
The major benefit of Olmecip 40mg is effective blood-pressure control. Lowering elevated blood pressure reduces stress on the heart and blood vessels and can help reduce the risk of serious cardiovascular complications over time.
Potential benefits include:
Helps lower elevated blood pressure
Promotes relaxation of blood vessels
Improves blood flow
Reduces strain on the cardiovascular system
Helps reduce the long-term risk associated with uncontrolled hypertension
Olmecip should be used regularly as prescribed rather than stopped simply because blood pressure or symptoms improve.
5. Side Effects of Olmecip 40mg
Like other medicines, Olmecip 40mg may cause side effects in some people. Not everyone experiences them.
Possible side effects include:
Dizziness
Headache
Cough
Diarrhea
Nausea
Indigestion or stomach discomfort
Runny nose
If side effects are persistent, severe, or unusual, the patient should consult their healthcare professional.
6. Common Side Effects
Some reported side effects associated with Olmecip/olmesartan include:
Dizziness
Headache
Diarrhea
Nausea
Indigestion or upset stomach
Cough
Runny nose
Dizziness can occur particularly when starting treatment or when blood pressure falls. Patients should take appropriate care when standing up quickly or performing activities requiring alertness.
7. How to Use Olmecip 40mg
Take Olmecip 40mg exactly as prescribed by your doctor.
Swallow the tablet with water.
It can generally be taken with or without food.
Try to take it at approximately the same time each day.
Do not crush or chew the tablet unless specifically instructed.
Do not change the dose or discontinue treatment without medical advice.
Continue treatment regularly even when you feel well, because hypertension may not cause noticeable symptoms.
The appropriate dose and treatment duration depend on the patient's blood pressure, medical history, response to treatment, and other medicines being taken.
8. How Olmecip 40mg Works
Olmecip 40mg contains Olmesartan Medoxomil, which is converted into its active form, olmesartan, after absorption.
Olmesartan belongs to the angiotensin II receptor blocker (ARB) class. Angiotensin II normally causes blood vessels to constrict. Olmesartan blocks the action of angiotensin II at its receptors, helping blood vessels relax and widen.
As the blood vessels become less constricted, blood can flow more easily and blood pressure decreases.
9. Safety Advice for Olmecip 40mg
Pregnancy: Olmesartan should not be used during pregnancy because medicines acting on the renin-angiotensin system can cause serious fetal harm. If pregnancy occurs during treatment, contact a doctor promptly.
Kidney problems: Tell your doctor if you have kidney disease. Kidney function may need to be monitored during treatment.
Liver problems: Inform your healthcare professional about existing liver disease before starting treatment.
Potassium: Olmesartan can affect potassium levels. Your doctor may monitor blood potassium, particularly when other medicines or conditions can increase potassium.
Dizziness: Blood-pressure reduction can sometimes cause dizziness. Rise slowly from sitting or lying positions, especially when beginning treatment.
Other medicines: Inform your doctor about all prescription medicines, over-the-counter medicines, and supplements you use.
Do not self-medicate: Olmecip 40mg is a prescription medicine and should be taken under appropriate medical supervision.
Storage: Follow the manufacturer's storage instructions and keep the medicine away from excessive heat, moisture, and direct sunlight. One current listing specifies storage below 30°C.
10. Frequently Asked Questions (FAQs)
Q1. What is Olmecip 40mg used for?
Olmecip 40mg is primarily used to treat and control high blood pressure (hypertension).
Q2. What is the active ingredient in Olmecip 40mg?
It contains Olmesartan Medoxomil 40mg.
Q3. Who manufactures Olmecip 40mg?
Olmecip 40mg is manufactured/marketed by Cipla Ltd.
Q4. Can Olmecip 40mg be taken with food?
Yes. It may generally be taken with or without food, according to the prescribing instructions.
Q5. Can I stop taking Olmecip when my blood pressure becomes normal?
Do not stop it without consulting your doctor. Blood pressure can rise again when treatment is discontinued.
Q6. Can Olmecip 40mg cause dizziness?
Yes. Dizziness is a reported possible side effect, particularly when blood pressure decreases.
Q7. Is Olmecip 40mg the same as Olmecip H 40mg?
No. Olmecip 40mg contains Olmesartan Medoxomil 40mg, whereas Olmecip H 40mg combines Olmesartan Medoxomil 40mg with Hydrochlorothiazide 12.5mg.
Q8. Is Olmecip 40mg a prescription medicine?
Yes. Current pharmacy listings classify Olmecip 40mg as a prescription medicine.
11. Substitute for Olmecip 40mg
Potential alternatives may contain the same active ingredient, Olmesartan Medoxomil 40mg, but brand availability differs by country.
Examples listed in Indian pharmacy sources include:
Olmighty 40 Tablet
Olsertain-40 Tablet
Olmepath-40 Tablet
Omnitrol 40mg Tablet
A substitute should not be selected solely on the basis of the same strength. A doctor or pharmacist should confirm that the alternative has the same active ingredient, dosage, formulation, and suitability for the patient.
12. Keywords
Product Keywords
Olmecip 40mg Tablets
Olmecip 40mg Tablet exporter
Olmecip 40mg supplier from India
Olmecip 40mg pharmaceutical exporter
Olmecip 40mg medicine supplier
Olmesartan Medoxomil 40mg Tablets
Olmesartan 40mg tablet supplier
Olmesartan Medoxomil exporter India
Olmecip 40mg wholesale supplier
Cipla Olmecip 40mg supplier
B2B & Export Keywords
Buy Olmecip 40mg from India
Olmecip 40mg international supplier
Olmecip 40mg global pharmaceutical supplier
Olmecip 40mg bulk medicine supplier
Olmecip 40mg wholesale pharmaceutical exporter
Indian medicine exporter Olmecip 40mg
Olmecip 40mg export supplier Nagpur
Olmesartan 40mg pharmaceutical exporter India
Genuine Olmecip 40mg medicine supplier
Olmecip 40mg B2B medicine supplier
Country-Based Keywords
Olmecip 40mg exporter from India to USA
Olmecip 40mg supplier to UK
Olmecip 40mg exporter to Australia
Olmecip 40mg supplier to Singapore
Olmecip 40mg exporter to Canada
Olmecip 40mg supplier to South Korea
Olmecip 40mg exporter to UAE
Olmesartan 40mg supplier India to USA
Olmesartan 40mg exporter India to UK
Olmesartan 40mg global export supplier
SEO Keywords
Olmecip 40mg tablets for hypertension
Olmecip 40mg blood pressure medicine
Olmesartan 40mg hypertension treatment
Olmecip 40mg antihypertensive tablets
Olmesartan Medoxomil 40mg supplier India
Trusted pharmaceutical exporter from Nagpur India
Phoenix Exim medicine exporter India
Phoenix Exim pharmaceutical supplier
Indian pharma exporter for international buyers
Olmecip 40mg medicine wholesale export
Keywords







